New heart procedure aims to zap stubborn arrhythmias

NCT ID NCT06940752

ENROLLING_BY_INVITATION Disease control Sponsor: National Heart, Lung, and Blood Institute (NHLBI) Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 34 times

Summary

This early study tests a new catheter technique called VINTAGE for people with ventricular arrhythmia that hasn't improved with standard treatment. The procedure uses special catheters to reach and destroy heart tissue causing the abnormal rhythm. Thirty adults will be enrolled and followed for 6 months to see if it reduces dangerous heart events.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: VINTAGE catheter ablation procedure
What this could lead to: If successful, this could offer a better way to treat ventricular arrhythmias that don't respond to standard ablation, reducing the need for shocks or hospital stays.
What could go wrong: This is a very early feasibility study with only 30 participants, so results may not apply to everyone. The procedure involves risks like bleeding, infection, or heart damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MONOMORPHIC VENTRICULAR TACHYCARDIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiac rhythm disease ventricular tachycardia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

VENTRICULAR ARRHYTHMIA

Contacts and locations

Locations

Emory University Hospital Midtown

Atlanta, Georgia, 30322-1102, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.